null
ChEBI ID: 38339
| Member | Definition | Role |
|---|---|---|
| 4,6-diamino-5-n-formamidopyrimidine | A member of the class of aminopyrimidines that is 4,6-diaminopyrimidine bearing an additional formamido substituent at position 5. A DNA lesion formed when DNA exposed to ionising radiation. | 4,6-diamino-5-formamidopyrimidine |
| 5-acetylamino-6-formylamino-3-methyluracil | 5-acetamido-6-formamido-3-methyluracil | |
| n(5)-methyl-n(5)-formyl-2,5,6-triamino-4-hydroxypyrimidine | A pyrimidine derivative having amino substituents in the 2- and 6-positions, a hydroxy substituent at the 4-position and an N-methylformamido group at the 5-position. | 2,6-diamino-4-hydroxy-5-(N-methylformamido)pyrimidine |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 18 (18.75) | 18.7374 |
| 1990's | 31 (32.29) | 18.2507 |
| 2000's | 30 (31.25) | 29.6817 |
| 2010's | 15 (15.63) | 24.3611 |
| 2020's | 2 (2.08) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 2 (1.92%) | 5.53% |
| Reviews | 2 (1.92%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 100 (96.15%) | 84.16% |